Citation Impact
2 by Nobel laureates 4 from Science/Nature 57 standout
Citing Papers
Translating p53-based therapies for cancer into the clinic
2024 Standout
Towards targeting the breast cancer immune microenvironment
2024 Standout
Works of C. Massard being referenced
Enriching phase I trials with molecular alterations: Interim analysis of 708 patients enrolled in the MOSCATO 01
2015
303 A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumors
2015
Author Peers
| Author | PRM | Oncology | Cancer Research | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| C. Massard | 127 | 84 | 54 | 137 | 38 | 317 | |
| Jean‐Baptiste Diéval | 28 | 10 | 526 | ||||
| Paola Belvedere | 15 | 21 | 23 | 266 | 49 | 1.4k | |
| Naoaki Hori | 83 | 9 | 4 | 187 | 24 | 417 | |
| Alexandra Tomova | 4 | 1 | 15 | 194 | 16 | 1.3k | |
| Angela Murphy Gardiner | 27 | 581 |
All Works
Loading papers...